Early Access — free while we kick the tires
EdgarHawk

ADTX Aditxt, Inc. Insider Trading

Latest: Insider Bought $64K of Shares · Jun 2026

Aditxt, Inc. (ADTX)'s reported leadership includes CEO Jeffrey M. Busch. Its Form 4 history breaks down as 6 buys and 0 sells, filed by 1 distinct insider through Jun 2026. Its highest-significance filing in the last 90 days: HRT Financial LP bought $64K, transaction dated Jun 2026.

6 filings analyzed · Latest 2026-06-24

Get alerts for ADTX

Free Form 4 email alerts, scored for significance — see how.

Buys
6
Sells
0
Insiders
1
Direction
Net buying

Aditxt, Inc. leadership

CEO
Jeffrey M. Busch — Interim Chief Executive Officer
CFO
Thomas J. Farley — Chief Financial Officer
Chair
Brian Brady — non-executive Chairman of the Board
June 2026
2026-06-24
low
7,340,178 shares
$95,422
@ $0.01
Significance 2

HRT Financial LP (10% owner) bought 7,340,178 shares at $0.01 & sold 5,120,480 shares at $0.02 in ADTX on 2026-06-18/22.

HRT Financial LP executed 2 separate transactions totaling a net purchase of 2,219,698 shares across a buy and a sell: 7,340,178 shares purchased for $95,422.31 on 2026-06-18 and 5,120,480 shares sold for $92,168.64 on 2026-06-22. The company is in severe financial distress, with annual revenue declining 97.6% and net income of -$15,947,725.00 for the most recent full fiscal year, while current market cap stands at $8,159.21. Trading activity occurs within a context of extreme stock volatility: the 52-week range is $0.00–$53451.08 with current price at $0.01, representing -100.0% from 52-week high and 30-day change of -98.1%. HRT Financial LP's cross-ticker track record shows 14 prior buys and 6 prior sells, though outcomes at this specific ticker (5 prior trades including this filing window) remain unmeasurable as they occurred within the last 90 days.

2026-06-16
medium
4,252,767 shares
$68,044
@ $0.02
Significance 2

HRT Financial LP bought 4.25M shares of ADTX at $0.02 on 2026-06-12; stock now at $0.01 (-100.0% from 52-week high).

HRT Financial LP, a 10% owner, purchased 4,252,767 shares at $0.02 per share for a total value of $68,044.27 on 2026-06-12, bringing post-transaction holdings to 2,459,308 shares. However, this trade came just 8 days after the same insider sold shares at $0.02, and both this buy and that prior sell have posted steep losses: the prior sell declined -70.2% and the preceding buy declined -75.7% over the 90-day period. The stock is now trading at $0.01, down -100.0% from a 52-week high of $53451.08 and -99.4% over 30 days, reflecting a company in severe distress: quarterly revenue stands at $12,159.00 with a net loss of $-15,947,725.00 and annual revenue contraction of -97.6%. At this ticker, HRT Financial's 2 prior trades are both underwater, with only 1 of 2 well-timed at the 90-day mark—a pattern inconsistent with successful market timing. The fundamental data and recent price collapse suggest this transaction reflects a highly speculative or distressed position rather than conviction in value recovery.

2026-06-11
critical
2,148,823 shares
$83,532
@ $0.04
Significance 2

HRT Financial LP bought 2,148,823 shares at $0.05–$0.02, sold 878,659 at $0.03; ADTX stock down 100.0% in 90 days, revenue off 97.6% YoY, company deeply unprofitable.

HRT Financial LP executed 2 purchases totaling 2,148,823 shares for $83,532.43 alongside 1 sale of 878,659 shares for $28,995.75 on 2026-06-08 through 2026-06-10, establishing a net long position of 1,040,004 shares post-transaction. However, the filing context reveals extreme distress: the current price is $0.01, representing -100.0% from the 52-week high and -99.6% over 30 days, with the company reporting only $12,159.00 in latest quarterly revenue, a net loss of $15,947,725.00, and annual revenue contraction of 97.6% year-over-year. At the same ticker, HRT's 2 prior trades on 2026-06-04 and 2026-06-05 both suffered severe losses (90-day returns of -75.7% and -70.2% respectively), suggesting pattern persistence rather than recovery. The filing documents insider accumulation into a company in fundamental collapse, not a position rooted in fundamental conviction or valuation opportunity.

2026-06-08
medium
843,622 shares
$64,115
@ $0.08
Significance 3

HRT Financial LP (10% owner) buys 843,622 shares at $0.08, sells 735,462 at $0.06; stock down -100.0% from 52-week high, revenue collapsed -97.6% YoY.

HRT Financial LP executed 2 transactions on consecutive days: purchased 843,622 shares at $0.08 on 2026-06-04 and sold 735,462 shares at $0.06 on 2026-06-05, resulting in a net long position of 108,160 shares. The trading occurred within a company facing severe distress—annual revenue growth declined -97.6%, net income was $-15,947,725.00, and the stock has fallen -100.0% from its 52-week high of $53451.08 to the current price of $0.05. Across his cross-ticker track record, the insider's 13 prior buys averaged +59.7% 90-day returns with a 60.00% win rate, but this positive historical pattern does not necessarily translate to timing accuracy at this specific ticker; his 2 prior ADTX trades in April remain unmeasurable at the 90-day horizon. The extreme fundamental deterioration and price collapse present material risk regardless of the insider's historical cross-ticker performance.

April 2026
2026-04-23
high
72,912 shares
$24,061
@ $0.33
Significance 6

10% owner HRT Financial LP bought 72,912 shares at $0.33 on 2026-04-21, then sold 11,982 shares at $0.30 on 2026-04-22.

HRT Financial LP executed 2 separate transactions within 24 hours: a purchase of 72,912 shares for $24,060.96 at $0.33, followed by a sale of 11,982 shares for $3,594.60 at $0.30 one day later. The net effect increased the 10% owner's holdings by 60,930 shares (+100.4% vs pre-transaction holdings of 60,662 shares). The company faces severe headwinds: annual revenue collapsed 97.6% and net income was negative $24,045,405.00 against quarterly revenue of $748.00, with market cap of only $7,063,895.08. The current price of $7.81 reflects a -100.0% decline from the 52-week high of $56382.48 and a -70.0% drop over 30 days. The near-simultaneous buy-and-sell pattern—purchase at a higher price than the subsequent sale—combined with the company's deteriorated fundamentals and severe price erosion creates an ambiguous signal that requires deeper investigation into the timing rationale and any associated trading plan restrictions.

October 2024
2024-10-17
high
15,636 shares
$23,454
@ $1.50
Significance 7

10% owner HRT FINANCIAL LP completes exit: bought 15,636 shares at $1.50 on 2024-10-15, sold 25,534 shares at $1.17 on 2024-10-16, holdings drop to 0 from 9,898 shares.

HRT FINANCIAL LP, a 10% owner, executed 2 separate transactions that resulted in a complete liquidation of its ADTX position. The insider purchased 15,636 shares at $1.50 on 2024-10-15 but then sold 25,534 shares at $1.17 on 2024-10-16—a lower price—for gross proceeds of $29,874.78. The net effect is a 100.0% reduction in holdings from 9,898 shares to 0 shares. This exit occurs within a context of severe deterioration: the stock is -99.7% from its 52-week high, down -94.0% over 30 days and -98.3% over 90 days. The company reported quarterly revenue of $44,276.00, a net loss of $-7,549,619.00, and annual revenue contraction of -30.9%, indicating sustained unprofitability. The insider's cross-ticker track record shows 5 prior sells with a 0.00% well-timed rate, suggesting a pattern of poorly executed exit decisions. Complete liquidation by a major shareholder during severe stock decline and negative fundamentals merits investor scrutiny.

Insiders here also file at

More Chemicals and Allied Products companies